sellmefear
← all entries

ONE SOURCE, MANY MASTHEADSMonday 17 August 2026

5 outlets carried this. They resolve to 1 independent source.

A reader sampling these outlets received 1 account, not 5.

As published

5 pages captured at the time, in each outlet's own typography. Open one to read the copy held outside the publisher's control.

5outlets1independent
What happened, for context

Zeus Hygia Lifesciences announced publication of a clinical study on Metaberine®, a bio-optimised berberine formulation, in the International Journal of Clinical Trials. The randomized, double-blind, placebo-controlled crossover trial of 36 healthy adults found that 200 mg daily dosing significantly improved markers of metabolic health including fasting glucose, GLP-1 response, and lipid parameters, with no adverse events reported.

4 of 5 articles were readable. Headline only, no body text retrieved, for: asiafoodjournal.com. Nothing below is drawn from those outlets beyond their headline.

Who reported it

    • asiafoodjournal.comUNCLASSIFIED
    • business-standard.comUNCLASSIFIED
    • theprint.inUNCLASSIFIED
    • thewire.inUNCLASSIFIED
    • tribuneindia.comUNCLASSIFIED
    identical copy

References

  • asiafoodjournal.comZeus Hygia’s Metaberine® clinical study published, demonstrating metabolic health benefits at just 200 mg dailyScreenshot as publishedOriginalcaptured 2026-08-17T18:29:09
  • business-standard.comZeus Hygia's Metaberine® Clinical Study Published, Demonstrating Metabolic Health Benefits at just 200 mg DailyScreenshot as publishedOriginalcaptured 2026-08-17T18:29:09
  • theprint.inZeus Hygia’s Metaberine® Clinical Study Published, Demonstrating Metabolic Health Benefits at just 200 mg DailyScreenshot as publishedOriginalcaptured 2026-08-17T18:29:09
  • thewire.inZeus Hygia’s Metaberine® Clinical Study Published, Demonstrating Metabolic Health Benefits at just 200 mg DailyScreenshot as publishedOriginalcaptured 2026-08-17T18:29:09
  • tribuneindia.comZeus Hygias Metaberine® Clinical Study Published, Demonstrating Metabolic Health Benefits at just 200 mg DailyScreenshot as publishedOriginalcaptured 2026-08-17T18:29:09

Carried by multiple outlets

  • Zeus Hygia Lifesciences announced publication of a clinical study evaluating Metaberine®, a bio-optimised berberine formulation developed using proprietary BioSOLVE® Technologybusiness-standard.com, theprint.in, thewire.in, tribuneindia.com
  • The study was published in the International Journal of Clinical Trialsbusiness-standard.com, theprint.in, thewire.in, tribuneindia.com
  • The study was a randomized, double-blind, placebo-controlled crossover trialbusiness-standard.com, theprint.in, thewire.in, tribuneindia.com
  • The study evaluated 36 healthy adults with fasting glucose levels of 100-125 mg/dLbusiness-standard.com, theprint.in, thewire.in, tribuneindia.com
  • Participants received Metaberine® 200 mg or placebo once daily for 14 days, followed by a seven-day washout periodbusiness-standard.com, theprint.in, thewire.in, tribuneindia.com
  • Fasting glucose decreased by 9.08 mg/dL with Metaberine® compared with 1.36 mg/dL with placebobusiness-standard.com, theprint.in, thewire.in, tribuneindia.com
  • and 4 more, not shown